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ABSTRACT
Background: The effect of mode of infant feeding on adiposity
deposition is not fully understood.
Objective: The objective was to test the hypothesis that differences
in total and regional adipose tissue content and intrahepatocellular
lipid (IHCL) arise in early infancy between breast- and formula-fed
infants and to describe longitudinal changes.
Design: This prospective longitudinal cohort study was performed
in 2 hospitals in the United Kingdom. Healthy, full-term, appropri-
ate weight-for-gestational age infants were recruited; adipose tissue
volume and distribution were directly quantified by using whole-
body magnetic resonance imaging; IHCL was assessed by in vivo
proton magnetic resonance spectroscopy. Measurements were per-
formed after birth (median age: 13 d) and at 6–12 wk of age.
Method of infant feeding was recorded prospectively by using ma-
ternally completed feeding diaries. Breastfed was defined as .80%
of feeds consisting of breast milk at both points; formula-fed was
defined as .80% of feeds consisting of formula milk at both points.
Results: Longitudinal results were obtained from 70 infants (36
breastfed, 9 mixed-fed, and 25 formula-fed). No differences were
found in total or regional adipose tissue or IHCL between breastfed
and formula-fed infants. In pooled analyses including all feeding
groups, IHCL and total adipose tissue approximately doubled be-
tween birth and 6–12 wk: IHCL after birth (median: 0.949; IQR:
0.521–1.711) and at 6–12 wk (1.828; 1.376–2.697; P , 0.001)
and total adipose tissue after birth (0.749 L; 0.620–0.928 L) and
at 6–12 wk (1.547 L; 1.332–1.790 L; P , 0.001). Increasing adi-
posity was characterized by greater relative increases in subcutane-
ous than in internal adipose tissue depots.
Conclusions: No differences were detectable in adipose tissue or
IHCL accretion between breastfed and formula-fed infants up to
2 mo. The substantial increase in IHCL seen over this period in
both breastfed and formula-fed infants is a novel observation, which
suggests that hepatic storage of lipids may be physiologic up to
2 mo. This trial was registered at www.clinicaltrials.gov as
NCT02033005. Am J Clin Nutr 2014;99:1034–40.
INTRODUCTION
Breastfeeding is considered the optimal diet for the human
infant. When compared with formula feeding, breastfeeding has
been associated with many health benefits (1, 2). An area that
remains contentious is the potential protective long-term effect of
breastfeeding on adiposity and the development of later obesity.
Numerous observational studies have described associations
between breastfeeding and lower rates of later obesity (3–5);
however, these may be a consequence of confounding by factors
such as socioeconomic class and maternal BMI (6, 7).
Patterns of growth (8) and body composition (9) differ between
formula and breastfed infants, with increasing deviation seen
between 6 mo and 1 y. Therefore, if breastfeeding does have
a positive effect on reducing later obesity, a plausible mediating
pathway may be through changes in the amount and distribution
of adipose tissue laid down in infancy as adiposity tracks from
infancy into adulthood (10). Previous studies that examined
infant adiposity in relation to feeding have been inconclusive and
limited by small sample sizes, cross-sectional designs, hetero-
geneity of infant feeding, and indirect measures of body adiposity
(11, 12). We previously developed the application of whole-body
MRI to quantify total and regional adipose tissue depots directly
in newborns (13, 14). We have also used in vivo magnetic res-
onance spectroscopy (MRS)4 to quantify intrahepatocellular
lipid (IHCL) deposition in preterm and term neonates (15, 16).
Although an association between breastfeeding in infancy and
fatty liver in later childhood has been reported (17), to our
knowledge no data describing longitudinal changes in IHCL in
early life or in relation to infant feeding have been published.
We aimed to test the null hypothesis that no differences in total
and regional adiposity and IHCL deposition in early infancy
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(up to 2–3 mo) exist between breastfed, mixed-fed, and formula-
fed infants. In addition, we aimed to provide longitudinal data
on these measures in healthy, full-term human infants over the
same period.
SUBJECTS AND METHODS
Participants consisted of infants from 2 cohorts with longi-
tudinal measures taken at 2 points: baseline (median age: 13 d)
and follow-up (6–12 wk). The first cohort consisted of healthy,
full term, appropriate weight-for-gestational age infants re-
cruited between November 1999 and October 2001 at the
Hammersmith Hospital, London, United Kingdom, and was
described previously (18). The second cohort consisted of
healthy, full-term, appropriate weight-for-gestational age infants
recruited between March 2010 and May 2012 from the postnatal
ward at Chelsea and Westminster Hospital, London, United
Kingdom.
In both cohorts, infants of diabetic mothers and mothers who
smoked—factors known to influence breast milk composition
(19, 20)—were excluded. Information on infant feeding was re-
corded prospectively by using a parent-completed feed diary and
was categorized as exclusively/predominantly breastfed (.80%
of feeds consisting of breast milk), exclusively/predominantly
formula-fed (.80% of feeds consisting of formula milk), or
mixed-fed (20–80% of feeds consisting of breast milk) (21).
Because we previously showed an association with infant ad-
iposity, we adjusted comparisons for maternal prepregnancy
BMI (16). This was determined from prepregnancy weight
obtained by maternal recall and maternal height measured at
pregnancy booking. Maternal BMI data were not available for
infants recruited from the Hammersmith Hospital.
Anthropometric measurements, whole-body MRI measure-
ment of adipose tissue volume, and hepatic MRS to quantify
IHCL were performed on infants at baseline and follow-up by
using identical techniques in both cohorts. Weight was measured
by using scales accurate to 0.2 g (Marsden Professional Baby
Scale). Magnetic resonance investigations were performed with
infants in natural sleep as previously described (22) at the Robert
Steiner Unit, Hammersmith Hospital.
Whole-body MRS images were acquired on a Phillips 1.5
Tesla system by using a T1-weighted rapid-spin-echo sequence
(repetition time of 500 ms, echo time of 17 ms, echo train length
of 3) by using a Q body coil. The slice thickness was 5 mm, and
the interslice difference was 5 mm. Voxel size was 0.313 0.313
0.31 cm. Scanning time was approximately 15 min. All MRS
images were analyzed independently of the investigators and
blind to participant identity and feeding group by VardisGroup
(www.vardisgroup.com) by using an image segmentation pro-
gram (SliceOmatic; Tomovision). Total adipose tissue volume
was calculated as the sum of 6 individually quantified adipose
tissue compartments: superficial subcutaneous abdominal, su-
perficial subcutaneous nonabdominal, deep subcutaneous ab-
dominal, deep subcutaneous nonabdominal, internal abdominal
(IA), and internal nonabdominal, as previously described (23).
Total subcutaneous adipose tissue was calculated as the sum of
abdominal superficial subcutaneous, abdominal deep sub-
cutaneous, nonabdominal superficial subcutaneous, and non-
abdominal deep subcutaneous. Total internal adipose tissue was
calculated as the sum of IA and internal nonabdominal. To
calculate the ratio of IA to total subcutaneous abdominal (SCA)
(IA:SCA), SCA comprised superficial subcutaneous abdominal
and deep subcutaneous abdominal compartments.
Proton magnetic resonance spectra were acquired from infants
recruited at Chelsea and Westminster Hospital at 1.5T from the
right lobe of the liver by using a point-resolved spectroscopy
sequence (24), a repetition time of 1500 ms, and an echo time of
135 ms without water saturation and with 128 signal averages.
Transverse images of the liver were used to ensure accurate
positioning of the (20 3 20 3 20 mm) voxel in the liver,
avoiding blood vessels, the gall bladder, and fatty tissue. Spectra
were analyzed in the time domain with the AMARES algorithm
included in the MRUI software package (25, 26) by a single
investigator (ELT) who was blind to the feeding category. Peak
areas for all resonances were obtained, and lipid resonances
were quantified with reference to water resonance after correc-
tion for T1 and T2 (27). Hepatic water, known to be relatively
constant (28), was used as an internal standard, and the results
are presented as the ratio of IHCL CH2 to water. Percentage
adipose tissue was calculated as previously described (13). The
study received approval by the National Research Ethics Com-
mittee (REC reference 10/H0713/5).
Statistical analyses
The analyses were performed by using SPSS version 20.
Statistical significance was defined as P , 0.05. Normality was
assessed by using the Shapiro-Wilk test (29). When data were
not normally distributed (P , 0.05 from the Shapiro-Wilk test),
a natural log transformation was undertaken. When data re-
mained nonnormal in distribution, nonparametric tests were
used.
To compare demographic factors, total and regional adiposity,
and IHCL between feeding groups, 1-factor ANOVA for normal
data or Kruskal-Wallis 1-factor ANOVA tests for nonnormal data
were used separately for baseline and follow-up.
We examined whether change in adiposity between baseline
and follow-up differed by feeding group. Multivariable re-
gression was used to examine the outcome (total or regional
adipose tissue volumes at follow-up) after adjustment for the
same adipose tissue compartment (or total adipose tissue) at
baseline, with formula-fed and mixed-fed groups compared with
breastfed infants. Adjustment was made for sex, maternal BMI,
and weight at follow-up, because these factors are associated with
infant adiposity. Because age at baseline was both variable and
associated with body size at baseline (and therefore adiposity),
sensitivity analyses were carried out with adjustment for
a measure of relative adiposity at baseline (percentage body mass
consisting of adipose tissue) instead of adipose compartment
volume at baseline. For the calculation of percentage adiposity,
adipose tissue volume was converted to adipose tissue mass by
using the following formula: adipose tissue mass = adipose tissue
volume 3 0.90 (13). To check for violation of regression as-
sumptions, standardized residuals were assessed for normality.
We described longitudinal changes in adiposity and IHCL
combining data if no differences were found between feeding
groups. To account for variation in postnatal age at baseline and
follow-up in longitudinal comparisons, total and regional adi-
posity data were standardized (assuming an infant-specific linear
relation with age between baseline and follow-up) to the median
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postnatal age at each scan. Because the linearity of the relation
between IHCL and postnatal age is unknown, these data were not
standardized. Longitudinal changes in adipose tissue volumes
and IHCL between baseline and follow-up were examined by
using the related-sample t test or related-samples Wilcoxon’s
signed-rank test if data were nonnormal. Correlations between
IHCL and adipose tissue volumes were examined by using
Spearman’s rank correlation.
Because ethnicity is associated with adiposity in infancy (23),
sensitivity analyses were undertaken after exclusion of nonwhite
infants. An additional sensitivity analysis was undertaken in-
cluding only exclusively breastfed and exclusively formula fed
infants.
Sample size
The study was powered to detect a difference in change in total
adipose tissue volume between baseline and follow-up between
feeding groups. The only previously published study directly
measuring adipose tissue in term infants in relation to method of
feeding included 15 infants; this study reported mean (6SD)
values for percentage adipose tissue of 26% 6 2.60% among
breastfed infants and 27.5% 6 2.37% among formula-fed in-
fants at 6 wk (18). To achieve 80% power (5% significance) to
detect a similar magnitude of difference at 12 wk, assuming
a correlation of 0.6 between measurements at baseline and
follow-up, we estimated that a minimum of 28 infants were
required in each of the exclusively/predominantly breastfed and
exclusively/predominantly formula-fed groups.
RESULTS
One hundred twenty-four infants were recruited, 16 of whom
were from the cohort recruited from the Hammersmith Hospital,
details of which were described previously (18), and 108 of
whom were from Chelsea and Westminster Hospital. Longitu-
dinal outcome data were available for 54 Chelsea and West-
minster infants (38 infants were withdrawn because their parents
were unable to attend, 33 before attending the first scan, and 5
between the first and second scans; 16 infants did not settle
sufficiently during the MR investigations).
In total, we acquired longitudinal outcome data for 70 in-
fants. At the first scan, 38 infants were fed .80% breast milk,
and 25 were fed .80% formula milk; at the second scan, 37
infants were fed .80% breast milk, and 27 were fed .80%
formula milk. Therefore, 36 infants (25 boys and 11 girls) were
exclusively/predominantly breastfed, 25 were exclusively/
predominantly formula-fed at both time points (10 boys and
15 girls), and 9 infants were mixed-fed (5 boys and 4 girls). The
infant formulas used included SMA First (Nestle UK Ltd), 12
infants; Aptamil First (Nutricia Ltd), 25 infants; and Cow &
Gate First Infant Milk (Nutricia Ltd), 3 infants (some infants
were fed more than one formula). Fifty-five infants were of
white origin, 12 of mixed origin, one of Asian origin, and 2 of
African origin.
Comparisons between breastfed, mixed-fed, and formula-
fed infants
All 70 infants were included in these analyses. Anthropo-
metric, adiposity, and IHCL data at baseline and follow-up by
feeding group are shown in Table 1; no significant differences
were detected between feeding groups in anthropometric mea-
sures, unadjusted total or regional adipose tissue volumes, or
IHCL at baseline or follow-up. After adjustment for adiposity or
IHCL at baseline, sex, weight at follow-up, and maternal BMI,
no significant differences were detected between feeding groups
in total or regional adipose tissue or IHCL (Table 2). Sensitivity
analyses including only exclusively breastfed (n = 16) and ex-
clusively formula-fed (n = 7) infants did not alter these con-
clusions. Sensitivity analyses after adjustment for percentage
adipose tissue at baseline instead of adiposity at baseline and
exclusion of nonwhite infants did not alter these conclusions. No
significant differences in the rate of change in total adipose
tissue, regional adiposity, or IHCL were found between feeding
groups (see Supplementary Table 1 under “Supplemental data”
in the online issue).
Longitudinal changes in adiposity
Data from all 70 infants were pooled in these analyses. Median
age at baseline was 13 d and at follow-up was 63 d; data for total
and regional adipose tissue were standardized to these postnatal
ages. Total adipose tissue volume approximately doubled be-
tween baseline and follow-up (Table 3). The magnitude of in-
crease differed between depots; the largest relative change
between baseline and follow-up occurred in the superficial
subcutaneous abdominal and deep subcutaneous abdominal de-
pots, and proportionally greater increases were seen in super-
ficial subcutaneous abdominal than in internal depots, as
evidenced by the significant decrease in the ratio of IA to SCA
(IA:SCA) adipose tissue between baseline and follow-up (P ,
0.001 from related-samples Wilcoxon’s signed-rank test) (Table
3).
Data for IHCL were not standardized to postnatal age. IHCL
approximately doubled between baseline (median: 0.949; IQR:
0.521–1.711) and follow-up (median: 1.828; IQR: 1.376–2.697);
P , 0.001 from related-samples Wilcoxon’s signed-rank test
(median percentage change: 113%; IQR: 218% to 284%). No
significant correlation was found between IHCL and total
adipose tissue or individual adipose tissue depots at baseline
or at follow-up (see Supplementary Table 2 under “Supple-
mental data” in the online issue) or between change in total
or individual adipose tissue depots and change in IHCL
between baseline and follow-up (see Supplementary Table 3
under “Supplemental data” in the online issue). Sensitivity
analyses after exclusion of nonwhite infants did not alter
these conclusions.
DISCUSSION
In this short-term, prospective, longitudinal, cohort study, we
identified no significant differences in adipose tissue content or
distribution or in IHCL content between healthy breastfed and
formula-fed infants at 2 mo. We made the novel observation that
over the first 2 postnatal months, there was an approximate
doubling of IHCL and that, over this period, adipose tissue ac-
cumulation occurred primarily within the subcutaneous depots
and that the relative contribution of internal depots to total ad-
iposity diminished. The key strengths of our study were the use of
gold standard direct measurement techniques, analyses of
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imaging and spectroscopy data blind to feeding category, pro-
spective recording of infant feeding, and broad inclusion criteria
supporting the generalizability of results to other healthy infant
populations.
IHCL estimated byMRS correlated well with values obtained
by liver biopsy (30, 31), and with hepatic steatosis in adult
studies (32), and was reproducible and not significantly affected
by the fasting state. In older children and adults hepatic lipid is
strongly associated with internal adipose tissue depots (33–37),
and its accumulation is considered pathological (38, 39). In
contrast, in healthy infants up to 2 mo of age, we showed
a marked expansion of hepatic lipid concurrent with a relative
diminution in internal adipose tissue and a substantial increase
in superficial adipose tissue stores. These data corroborate
evidence from a previous cross-sectional study in which we
suggested that IHCL might increase over the early postnatal
period (16). In lean fit adults, IHCL is virtually undetectable
(40) and the values we report at 6–12 wk are higher in mag-
nitude than values seen in healthy, lean adults (27, 41). Nec-
ropsy studies of stillbirths and neonatal deaths previously
showed hepatic lipid accumulation in early infancy, which has
been considered indicative of steatosis or pathological de-
position (42, 43). We suggest that, in human infants over the
first postnatal months, hepatic lipid may represent a physio-
logic rather than a pathological energy store, similar to that
seen in migratory birds before seasonal journeys (44) and in
other mammal species before hibernation (45). In early infancy
the deposition of lipid in adipose tissue and in the liver, as
a readily mobilizable energy source, would agree with evolu-
tionary pressure to safeguard the infant through the period of
nutritional insecurity around weaning. Animal data support
these findings; hepatic lipoprotein lipase is not expressed in
adult humans or animals; however, high concentrations of
hepatic lipoprotein lipase have been shown in neonatal rats
(46) and mice (47), in which expression parallels hepatic tri-
acylglycerol accumulation and is enhanced during periods of
starvation (48). To our knowledge, hepatic lipoprotein lipase
expression has not been examined in human infants, but dif-
ferential expression during development offers a possible ex-
planation for the increase in IHCL that we describe up to 2 mo.
TABLE 3
Total AT volume and AT compartment volumes among the combined cohort, postnatal age at scan standardized to 13 d for
baseline and 63 d for follow-up1
Baseline
(n = 69)
Follow-up
(n = 69)
Change
(n = 69)
L L %
Total AT 0.749 (0.620–0.928) 1.547 (1.332–1.790) 105 (69–140)
Superficial subcutaneous abdominal AT 0.106 (0.0791–0.132) 0.267 (0.204–0.321) 138 (90–208)
Superficial subcutaneous nonabdominal AT 0.551 (0.445–0.687) 1.066 (0.942–1.277) 101 (63–137)
Deep subcutaneous abdominal AT 0.016 (0.012–0.022) 0.039 (0.031–0.049) 131 (80–196)
Deep subcutaneous nonabdominal AT 0.013 (0.010–0.015) 0.020 (0.016–0.024) 53 (20–98)
Internal abdominal AT 0.019 (0.013–0.026) 0.028 (0.022–0.042) 69 (9–147)
Internal nonabdominal AT 0.053 (0.044–0.069) 0.085 (0.071–0.115) 62 (23–133)
Total subcutaneous AT 0.688 (0.544–0.867) 1.446 (1.210–1.676) 109 (70–148)
Total internal AT 0.074 (0.058–0.096) 0.134 (0.100–0.148) 76 (21–117)
IA:SCA 0.15 (0.11–0.19)2 0.10 (0.08–0.14)2 —
1All values are medians; IQR in parentheses. AT, adipose tissue; IA, internal abdominal; SCA, total subcutaneous
abdominal.
2 P , 0.001 from related samples (Wilcoxon’s signed-rank test).
TABLE 2
Mean difference in adiposity and IHCL at follow-up compared with breastfed infants (adjusted for adiposity or IHCL at baseline, sex, weight at follow-up,
and maternal BMI)1
R2 Formula-fed Mixed-fed P2
Total AT (L) 0.65 20.057 (20.234, 0.121) 0.038 (20.232, 0.308) 0.73
Superficial subcutaneous abdominal AT (L) 0.57 20.012 (20.055, 0.032) 0.003 (20.063, 0.069) 0.84
Superficial subcutaneous nonabdominal AT (L) 0.65 20.023 (20.146, 0.100) 0.067 (20.119, 0.253) 0.64
Deep subcutaneous abdominal AT (L) 0.36 20.004 (20.013, 0.05) 0.005 (20.009, 0.018) 0.38
Deep subcutaneous nonabdominal AT (% difference) 0.40 214.1 (234.8, 13.2) 13.3 (225.4, 72.0) 0.373
IA AT (L) 0.17 0.004 (20.007, 0.015) 20.008 (20.025, 0.008) 0.39
Internal nonabdominal AT (L) 0.29 20.005 (20.027, 0.017) 20.008 (20.042, 0.025) 0.84
Total subcutaneous AT (L) 0.61 20.048 (20.209, 0.113) 0.068 (20.177, 0.313) 0.63
Total internal AT (L) 0.20 20.001 (20.029, 0.031) 20.018 (20.061, 0.025) 0.70
IA:SCA 0.18 0.02 (20.01, 0.04) 20.02 (20.06, 0.02) 0.15
IHCL (% difference)4 0.23 213.6 (251.1, 52.7) 249.3 (278.2, 7.6) 0.273
1 n = 47 (29 breastfed, 4 mixed-fed, and 14 formula-fed); reduced n reflects the lack of maternal BMI data in some infants. Data are means, except where
indicated otherwise; 95% CIs in parentheses. AT, adipose tissue; IA, internal abdominal; IHCL, intrahepatocellular lipid; SCA, total subcutaneous abdominal.
2Represents significance of the method of feeding in the overall analyses including all feeding groups (from multivariable regression).
3 From multivariable regression of natural log-transformed data (performed by using transformed data due to nonnormal distribution of residuals).
4Ratio of CH2 to water.
1038 GALE ET AL
 at UNIVERSITY O
F W
ESTM
INSTER on O
ctober 6, 2014
ajcn.nutrition.org
D
ow
nloaded from
 
We previously showed in a meta-analysis, in which a variety of
body-composition methods were used, that healthy breastfed
infants have a higher fat mass than their formula-fed counterparts
before weaning (9). We were unable to corroborate this finding in
our current study, but we accept that the weaknesses of this study
included the limited power to detect subtle differences between
breastfed and formula-fed infants, that the use of a cutoff of 80%
feeds consisting of breast milk or formula milk to define the
feeding groups may not have been sufficiently discriminatory
to produce statistical differences between the breastfed and
formula-fed groups, and that, although we adjusted for sex, we
did not consider it appropriate to run separate analyses for boys
and girls because of the small numbers involved. We addressed
the variation in postnatal age at baseline and follow-up exami-
nations and the diverse ethnicity of the population through
standardization of adiposity for postnatal age and sensitivity
analyses. The absence of biochemical measures in our cohort left
us unable to comment on whether the hepatic lipid accumulation
we described was associated with altered glucose metabolism—
a phenomenon well described in adults (34).
An increase in subcutaneous adiposity arising in the pre-
weaning period would be in keeping with evolutionary theory
proposing that this substantial energy store promoted the de-
velopment of the energy-avid, larger human brain (49). We
anticipated that IHCL and relative adiposity would decline after
weaning, but we were unable to obtain further measurements
later in infancy to examine this possibility because MR in-
vestigations in later infancy are precluded by the increasing
difficulty in keeping older infants settled in natural sleep and our
view that it is not ethical to use sedation for exploratory ob-
servational studies (22). In light of observational data indicating
a protective effect of breastfeeding on progression of non-
alcoholic fatty liver disease in childhood (17), the lack of
a relation between method of feeding and IHCL or change in
IHCL in the first 2 postnatal months is of note and adds further
weight to our suggestion that IHCL accumulation in early in-
fancy is a normal developmental phenomenon. Resolution of
these uncertainties requires longitudinal follow-up of a larger
cohort across infancy and into childhood using noninvasive
techniques.
The effect of early postnatal nutrition on later body compo-
sition is of considerable interest given the high worldwide
prevalence of obesity and the rising mortality and morbidity from
obesity-associated chronic noncommunicable diseases (50).
Breastfeeding is commonly cited as a means to reduce the risk of
later overweight and obesity (51). Several observational studies
have identified an association between breastfeeding and reduced
risk of later obesity (3–5). However, studies in which the pos-
sibility of confounding is more fully addressed, through use of
individual patient data to allow for the most accurate treatment
of confounding factors in meta-analyses (6) or comparison of
populations with different confounding structures (7), have
failed to show a significant association. In addition, a cluster
randomized controlled trial of the WHO/UNICEF Baby
Friendly intervention to promote breastfeeding found no sig-
nificant effect on overweight or obesity at age 11.5 y (52). These
findings cast doubt on the suggested causal effect of breast-
feeding on later obesity or overweight. When interpreted in
the context of these longer-term studies, our data, although
only pertaining to the first few months of life, are of interest
because of the failure to detect an effect of formula feeding on
adiposity—a proposed mediator of later body composition. It is,
however, important to recognize the limited duration of our
study. For the reasons discussed above, we were unable to ex-
amine adipose tissue content and distribution in later infancy—
a period when indirect techniques have detected increasing
divergence in body composition between breast and formula-fed
populations (9).
In conclusion, we found no evidence to support method of
feeding as a factor influencing infant adiposity in the first 2–3 mo
of life. Our data do, however, contribute to our understanding of
the ontogeny of body composition and energy stores in early
infancy.
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